Sugar Could Replace Contrast Agents in Brain MRI Scans
By MedImaging International staff writers Posted on 05 Jul 2017 |
Image: Visualization of brain cancer by conventional contrast agents (L) and using glucose MRI method (R) (Photo courtesy of DKFZ).
A new study suggests that glucose metabolism activity identified using magnetic resonance imaging (MRI) could help identify solid tumors or very aggressively growing tumor areas.
Researchers at the German Cancer Research Center (DKFZ; Heidelberg, Germany), the Max-Planck-Institute for Biological Cybernetics (Tuebingen, Germany), and other institutions used an ultrahigh field 7 Tesla MRI scanner to detect intracerebral regions of increased glucose concentration. For the study, they examined nine patients with newly diagnosed glioblastoma and four healthy volunteers between October 2015 and July 2016.
T1ρ-weighted dynamic glucose-enhanced (DGE) MRI was performed with injection of 100 mL of 20% d-glucose via the cubital vein. Glucose enhancement, given by the relative signal intensity change, was then quantitatively investigated in brain gray matter versus white matter in the healthy volunteers, and in tumor tissue versus normal-appearing white matter of patients with glioblastoma. The median signal intensities of the assessed brain regions were then compared.
The results demonstrated that in healthy volunteers, the median signal intensity in basal ganglia gray matter was significantly increased compared with that in white matter tissue. But in the glioblastoma patients, the median signal intensity in the glucose-enhanced tumor region, as displayed on the T1ρ-weighted DGE images, was significantly higher than that in contralateral normal-appearing white matter, indicating the pathophysiologically increased glucose uptake that occurs in human brain cancer. The study was published on June 23, 2017, in Radiology.
“We do not know yet how the shares of measured glucose are distributed between vessels and extracellular spaces on the one hand, and the cell interior on the other,” said study co-author radiologist Heinz-Peter Schlemmer, MD, PhD, of the DKFZ division of radiology. “If we can confirm that substantial signal levels originate from glucose in the cell interior, this would be important additional information for tumor imaging and functional MRI. This could enhance therapy planning and monitoring.”
MRI contrast agents enhance signals in blood vessels and in spaces between cells, but do not reach the interior of the cell; by contrast, glucose is taken up and then broken down in the body cells, and tumor cells are particularly hungry for glucose in order to feed their high-energy needs. As glucose is found at much lower levels in the body, magnetization transfer effect is used to reinforce the glucose signal by transferring the signal from glucose protons to bodily water, which is measured in MRI. The amount of glucose needed corresponds to about five sugar cubes.
Related Links:
German Cancer Research Center
Max-Planck-Institute for Biological Cybernetics
Researchers at the German Cancer Research Center (DKFZ; Heidelberg, Germany), the Max-Planck-Institute for Biological Cybernetics (Tuebingen, Germany), and other institutions used an ultrahigh field 7 Tesla MRI scanner to detect intracerebral regions of increased glucose concentration. For the study, they examined nine patients with newly diagnosed glioblastoma and four healthy volunteers between October 2015 and July 2016.
T1ρ-weighted dynamic glucose-enhanced (DGE) MRI was performed with injection of 100 mL of 20% d-glucose via the cubital vein. Glucose enhancement, given by the relative signal intensity change, was then quantitatively investigated in brain gray matter versus white matter in the healthy volunteers, and in tumor tissue versus normal-appearing white matter of patients with glioblastoma. The median signal intensities of the assessed brain regions were then compared.
The results demonstrated that in healthy volunteers, the median signal intensity in basal ganglia gray matter was significantly increased compared with that in white matter tissue. But in the glioblastoma patients, the median signal intensity in the glucose-enhanced tumor region, as displayed on the T1ρ-weighted DGE images, was significantly higher than that in contralateral normal-appearing white matter, indicating the pathophysiologically increased glucose uptake that occurs in human brain cancer. The study was published on June 23, 2017, in Radiology.
“We do not know yet how the shares of measured glucose are distributed between vessels and extracellular spaces on the one hand, and the cell interior on the other,” said study co-author radiologist Heinz-Peter Schlemmer, MD, PhD, of the DKFZ division of radiology. “If we can confirm that substantial signal levels originate from glucose in the cell interior, this would be important additional information for tumor imaging and functional MRI. This could enhance therapy planning and monitoring.”
MRI contrast agents enhance signals in blood vessels and in spaces between cells, but do not reach the interior of the cell; by contrast, glucose is taken up and then broken down in the body cells, and tumor cells are particularly hungry for glucose in order to feed their high-energy needs. As glucose is found at much lower levels in the body, magnetization transfer effect is used to reinforce the glucose signal by transferring the signal from glucose protons to bodily water, which is measured in MRI. The amount of glucose needed corresponds to about five sugar cubes.
Related Links:
German Cancer Research Center
Max-Planck-Institute for Biological Cybernetics
Latest MRI News
- World's First Sensor Detects Errors in MRI Scans Using Laser Light and Gas
- Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans
- Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients
- PET/MRI Improves Diagnostic Accuracy for Prostate Cancer Patients
- Next Generation MR-Guided Focused Ultrasound Ushers In Future of Incisionless Neurosurgery
- Two-Part MRI Scan Detects Prostate Cancer More Quickly without Compromising Diagnostic Quality
- World’s Most Powerful MRI Machine Images Living Brain with Unrivaled Clarity
- New Whole-Body Imaging Technology Makes It Possible to View Inflammation on MRI Scan
- Combining Prostate MRI with Blood Test Can Avoid Unnecessary Prostate Biopsies
- New Treatment Combines MRI and Ultrasound to Control Prostate Cancer without Serious Side Effects
- MRI Improves Diagnosis and Treatment of Prostate Cancer
- Combined PET-MRI Scan Improves Treatment for Early Breast Cancer Patients
- 4D MRI Could Improve Clinical Assessment of Heart Blood Flow Abnormalities
- MRI-Guided Focused Ultrasound Therapy Shows Promise in Treating Prostate Cancer
- AI-Based MRI Tool Outperforms Current Brain Tumor Diagnosis Methods
- DW-MRI Lights up Small Ovarian Lesions like Light Bulbs